Literature DB >> 9849578

Prevention of N-methylnitrosourea-induced colon tumorigenesis by ursodeoxycholic acid in F344 rats.

T Narisawa1, Y Fukaura, K Terada, H Sekiguchi.   

Abstract

Bile acids are known to promote colon carcinogenesis. However, there is one study showing that ursodeoxycholic acid (UDCA) supplemented in the diet at the concentration of 0.4% prevented azoxymethane-induced rat colon tumorigenesis. The aim of our study was to explore the inhibitory effect of a much smaller dose of UDCA on colon carcinogenesis in rats. One hundred 7-week-old F344 rats were given 2 mg of N-methylnitrosourea 3 times a week for 3 weeks by intrarectal instillation, and were fed a 0% (control), 0.4% or 0.08% UDCA-supplemented diet for the next 27 weeks. All the rats were killed and examined for tumor development at week 30. The tumor incidence and number were significantly lower and smaller, respectively, in the UDCA-fed rats than in the control rats: 40% and 36% vs. 68%; 0.5 +/- 0.1 (mean +/- SEM) and 0.4 +/- 0.1 vs. 1.0 +/- 0.2. All the tumors were located in the distal half of the colon and were plaque-shaped or polypoid, being well-differentiated adenocarcinomas restricted to the mucosa or submucosa. Bile acids in the feces and the blood obtained at weeks 20 and 30, respectively, were analyzed by HPLC. A significant increase of UDCA was confirmed in both the feces and the blood of the UDCA-fed rats compared with the control rats. The results suggest that the continuous feeding of a small dose of UDCA may prevent colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849578      PMCID: PMC5921693          DOI: 10.1111/j.1349-7006.1998.tb00489.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  17 in total

1.  Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats.

Authors:  B S Reddy; K Watanabe; J H Weisburger; E L Wynder
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

2.  Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats.

Authors:  T Narisawa; N E Magadia; J H Weisburger; E L Wynder
Journal:  J Natl Cancer Inst       Date:  1974-10       Impact factor: 13.506

3.  Effect of cholic acid feeding on N-methyl-N-nitrosourea-induced colon tumors and cell kinetics in rats.

Authors:  B I Cohen; R F Raicht; E E Deschner; M Takahashi; A N Sarwal; E Fazzini
Journal:  J Natl Cancer Inst       Date:  1980-03       Impact factor: 13.506

4.  Anti-angiogenic activity of ursodeoxycholic acid and its derivatives.

Authors:  H Suh; E J Jung; T H Kim; H Y Lee; Y H Park; K W Kim
Journal:  Cancer Lett       Date:  1997-02-26       Impact factor: 8.679

5.  Differential effects of deoxycholic acid on proliferation of neoplastic and differentiated colonocytes in vitro.

Authors:  L P Peiffer; D J Peters; T J McGarrity
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

6.  Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate.

Authors:  A Hague; D J Elder; D J Hicks; C Paraskeva
Journal:  Int J Cancer       Date:  1995-01-27       Impact factor: 7.396

7.  Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta.

Authors:  R K Wali; B P Frawley; S Hartmann; H K Roy; S Khare; B A Scaglione-Sewell; D L Earnest; M D Sitrin; T A Brasitus; M Bissonnette
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

8.  Effects of dietary bile acids on formation of azoxymethane-induced aberrant crypt foci in F344 rats.

Authors:  M J Seraj; A Umemoto; A Kajikawa; S Mimura; T Kinouchi; Y Ohnishi; Y Monden
Journal:  Cancer Lett       Date:  1997-05-01       Impact factor: 8.679

9.  Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk.

Authors:  H Garewal; H Bernstein; C Bernstein; R Sampliner; C Payne
Journal:  Cancer Res       Date:  1996-04-01       Impact factor: 12.701

10.  Bile acids, but not neutral sterols, are tumor promoters in the colon in man and in rodents.

Authors:  J H Weisburger; B S Reddy; W S Barnes; E L Wynder
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

View more
  11 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.

Authors:  Kunrong Cheng; Guofeng Xie; Jean-Pierre Raufman
Journal:  Biochem Pharmacol       Date:  2006-12-10       Impact factor: 5.858

Review 3.  Update on inflammatory bowel disease in patients with primary sclerosing cholangitis.

Authors:  Christos Tsaitas; Anysia Semertzidou; Emmanouil Sinakos
Journal:  World J Hepatol       Date:  2014-04-27

4.  Ursodeoxycholic acid in patients with ulcerative colitis and primary sclerosing cholangitis for prevention of colon cancer: a meta-analysis.

Authors:  Imran Ashraf; Abhishek Choudhary; Murtaza Arif; Michelle L Matteson; Hazem T Hammad; Srinivas R Puli; Matthew L Bechtold
Journal:  Indian J Gastroenterol       Date:  2012-04-14

5.  Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling.

Authors:  Jean-Pierre Raufman; Jasleen Shant; Chang Yue Guo; Sanjit Roy; Kunrong Cheng
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

Review 6.  Ursodiol and colorectal cancer or dysplasia risk in primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis.

Authors:  Jonathan D Hansen; Sonal Kumar; Wai-Kit Lo; David M Poulsen; Umme-Aiman Halai; Kathy C Tater
Journal:  Dig Dis Sci       Date:  2013-07-30       Impact factor: 3.199

7.  Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter.

Authors:  Xiaowan Zheng; Sean Ekins; Jean-Pierre Raufman; James E Polli
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

8.  Ursodeoxycholic acid treatment in a rat model of cancer cachexia.

Authors:  Anika Tschirner; Stephan von Haehling; Sandra Palus; Wolfram Doehner; Stefan D Anker; Jochen Springer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-10-21       Impact factor: 12.910

9.  Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats.

Authors:  Tomio Narisawa; Yoko Fukaura; Naomi Takeba; Keiko Nakai
Journal:  Jpn J Cancer Res       Date:  2002-02

10.  Muscarinic receptor signaling in colon cancer.

Authors:  Erik C Von Rosenvinge; Jean-Pierre Raufman
Journal:  Cancers (Basel)       Date:  2011-03-02       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.